Enrichment of nucleic acid targets
View Patent ↗Methods and apparatus providing improved fidelity and specificity when separating nucleic acids from a sample, but without need for amplification. In particular, using the disclosed methods, it is possible to isolate a variant nucleic acid (i.e., a mutation) from a non-target nucleic acid (i.e., a wild-type) when the variant is present in the original sample at a much lower concentration than the non-target, e.g., 1:10,000, without substantial loss of the variant.
1. A method for enriching a sample, the method comprising the steps of:
obtaining a sample comprising a non-target nucleic acid and a target nucleic acid, the target nucleic acid and the non-target nucleic acid differing by an insertion, a deletion, or a polymorphism at a position of interest, but being no more than 50 bases different in total length, wherein the target to non-target ratio in the sample is X; and
enriching for the target nucleic acid by applying a time-varying driving field to the sample in the presence of a separation medium,
wherein after enrichment the ratio of target nucleic acid to non-target nucleic acid is Y, wherein Y is at least 10 times greater than X.
2. The method of claim 1 , wherein the target and the non-target nucleic acids differ in length by 20 or fewer bases.
3. The method of claim 2 , wherein the target and the non-target nucleic acids differ in length by 10 or fewer bases.
4. The method of claim 1 , wherein the target and the non-target nucleic acids have different methylation or acetylation patterns.
5. The method of claim 1 , wherein the sample is a biological sample.
6. The method of claim 5 , wherein the biological sample comprises tissue, blood, sputum, sweat, urine, feces, tears, aspirate, or a combination thereof.
7. The method of claim 6 , wherein the biological sample is from a human.
8. The method of claim 1 , further comprising identifying the target nucleic acid.
9. The method of claim 8 , wherein identifying comprises sequencing at least a portion of the target nucleic acid, contacting the target nucleic acid with a labeled moiety, or an amplification-based detection.
10. The method of claim 1 , wherein the presence of the target nucleic is indicative of a disorder.
11. The method of claim 10 , wherein the disorder is a genetic disorder.
12. The method of claim 10 , wherein the disorder is cancer.
13. The method of claim 1 , wherein Y is at least 100 times greater than X.
14. The method of claim 13 , wherein Y is at least 1,000 times greater than X.
15. The method of claim 1 , wherein enriching comprises applying a periodic electric field to the sample.
16. The method of claim 15 , further comprising periodically changing the temperature of the medium.
17. The method of claim 1 , wherein the non-target and target nucleic acids each comprise 5000 or fewer bases.
18. The method of claim 1 , wherein the non-target and target nucleic acids each comprise 100 or more bases.
19. The method of claim 1 , wherein the non-target nucleic acid is a wild-type nucleic acid.
20. The method of claim 1 , wherein at least 20% of the target nucleic acid in the sample comprising a non-target nucleic acid and a target nucleic acid is recovered after enrichment.
21. The method of claim 20 , wherein at least 50% of the target nucleic acid in the sample comprising a non-target nucleic acid and a target nucleic acid is recovered after enrichment.
22. The method of claim 1 , wherein the sample is simultaneously enriched for more than one target nucleic acid.